Recent research indicate that the CAG-Sema peptide represents a innovative clinical approach for addressing various neurological diseases. This molecule , created to modulate RA , shows remarkable promise in laboratory models , notably regarding SMA and related neurological conditions. Additional investigation into its mode of operation and pati… Read More